AU2001262554A1 - Inhibiting denaturation of nucleic acid duplexes - Google Patents

Inhibiting denaturation of nucleic acid duplexes

Info

Publication number
AU2001262554A1
AU2001262554A1 AU2001262554A AU6255401A AU2001262554A1 AU 2001262554 A1 AU2001262554 A1 AU 2001262554A1 AU 2001262554 A AU2001262554 A AU 2001262554A AU 6255401 A AU6255401 A AU 6255401A AU 2001262554 A1 AU2001262554 A1 AU 2001262554A1
Authority
AU
Australia
Prior art keywords
nucleic acid
acid duplexes
inhibiting denaturation
inhibiting
denaturation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001262554A
Inventor
Matthew Baker
Neil Butt
Navin Pathirana
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Whatman BioScience Ltd
Original Assignee
Whatman BioScience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Whatman BioScience Ltd filed Critical Whatman BioScience Ltd
Publication of AU2001262554A1 publication Critical patent/AU2001262554A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A solution for treating a nucleic acid duplex having a pH of from 3 to 11, comprising a soluble protein or mixture of proteins; and 0.1 mM to 10 mM divalent cations; wherein the nature and concentration of the protein or mixture of proteins is selected so that the solution is capable of inhibiting heat denaturation of a nucleic acid product.
AU2001262554A 2000-06-12 2001-06-11 Inhibiting denaturation of nucleic acid duplexes Abandoned AU2001262554A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0014324 2000-06-12
GB0014324A GB2363381B (en) 2000-06-12 2000-06-12 Solution
PCT/GB2001/002564 WO2001096351A1 (en) 2000-06-12 2001-06-11 Inhibiting denaturation of nucleic acid duplexes

Publications (1)

Publication Number Publication Date
AU2001262554A1 true AU2001262554A1 (en) 2001-12-24

Family

ID=9893476

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001262554A Abandoned AU2001262554A1 (en) 2000-06-12 2001-06-11 Inhibiting denaturation of nucleic acid duplexes

Country Status (7)

Country Link
US (2) US7244561B2 (en)
EP (1) EP1290003B1 (en)
AT (1) ATE312113T1 (en)
AU (1) AU2001262554A1 (en)
DE (1) DE60115637T2 (en)
GB (1) GB2363381B (en)
WO (1) WO2001096351A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0129662D0 (en) * 2001-12-11 2002-01-30 Whatman Internat Ltd Stabilisation of double-stranded nucleic acids
US7794932B2 (en) * 2004-04-16 2010-09-14 Piotr Chomczynski Reagents and methods for isolation of purified RNA
EP3115039B1 (en) * 2015-07-09 2021-12-15 beniag GmbH Method for producing a fusion mixture for transferring a charged molecule into and/or through a lipid membrane

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668618A (en) * 1981-09-14 1987-05-26 Thornthwaite Jerry T Nuclear isolation medium and procedure for separating cell nuclei
EP0310913A3 (en) * 1987-09-30 1990-04-25 Biotechnica Diagnostics Inc Dna isolation procedure
US5756126A (en) * 1991-05-29 1998-05-26 Flinders Technologies Pty. Ltd. Dry solid medium for storage and analysis of genetic material
CA2031659A1 (en) * 1990-01-26 1991-07-27 John B. Findlay Water-insoluble reagent, nucleic acid probe, test kit and diagnostic and purification methods
US5866429A (en) * 1991-04-03 1999-02-02 Bloch; Will Precision and accuracy of anion-exchange separation of nucleic acids
WO1992018649A1 (en) * 1991-04-12 1992-10-29 Microprobe Corporation Compositions and methods for improved extraction and hybridization of nucleic acid
AU7375794A (en) * 1993-07-28 1995-02-28 Akzo Nobel N.V. Process for isolating nucleic acid from gram positive microorganisms
EP0814156B1 (en) * 1996-06-18 2003-03-05 The Institute Of Physical & Chemical Research Method for the purification of DNA
US5922536A (en) * 1996-10-18 1999-07-13 Nivens; David E. Method for nucleic acid isolation using supercritical fluids
US6844158B1 (en) * 1997-12-22 2005-01-18 Hitachi Chemical Co., Ltd. Direct RT-PCR on oligonucleotide-immobilized PCR microplates
DE69908795T2 (en) 1998-10-09 2004-04-22 Whatman Bioscience Ltd., Abington METHOD FOR ISOLATING NUCLEIC ACID AND DEVICE THEREFOR
WO2002014560A1 (en) * 2000-08-16 2002-02-21 Whatman, Inc. Transfusion medicine leukodepletion filter devices as a source of genetic material for genotyping studies

Also Published As

Publication number Publication date
DE60115637T2 (en) 2006-08-24
GB2363381A (en) 2001-12-19
EP1290003B1 (en) 2005-12-07
US20030157520A1 (en) 2003-08-21
GB0014324D0 (en) 2000-08-02
WO2001096351A1 (en) 2001-12-20
US20070281316A1 (en) 2007-12-06
DE60115637D1 (en) 2006-01-12
EP1290003A1 (en) 2003-03-12
US7244561B2 (en) 2007-07-17
US7501500B2 (en) 2009-03-10
ATE312113T1 (en) 2005-12-15
GB2363381B (en) 2004-11-24

Similar Documents

Publication Publication Date Title
DE69508192D1 (en) WATER-SOLUBLE NIMESULIDE SALT AND THE USE THEREOF FOR TREATING IGNITIONS
PL324285A1 (en) Pyrollepyrimidines and methods of obtaining them
EP1364585A4 (en) Soybean protein, process for producing the same and acidic protein foods with the use of the same
WO2001058275A3 (en) Use of acid-stable subtilisin proteases in animal feed
BR9811509A (en) Water-stabilized organo-silane compounds and methods for using them.
IL109780A0 (en) Saccharin derivative proteolytic enzyme inhibitors, their preparation and pharmaceutical compositions containing them
WO2003022222A3 (en) Antisense modulation of protein kinase r expression
DE60002678D1 (en) SYSTEM FOR ENRICHING WITH IRON
AU2001262554A1 (en) Inhibiting denaturation of nucleic acid duplexes
AU2001289034A1 (en) Novel pdes and uses thereof
ATE207116T1 (en) METHOD FOR PURIFYING AN AQUEOUS ENZYME SOLUTION
AU1559501A (en) Apoptosis inducing proteinaceous substance
ATE312179T1 (en) AGENT CONTAINING SERINE-THREONINE KINASE FOR TUMOR THERAPY AND TUMOR DIAGNOSIS
WO2001054707A3 (en) Modification of surface proteins by aminopeptidase inhibitors
ATE355260T1 (en) METHOD FOR PURIFYING CUMENE HYDROPEROXIDE DECISION PRODUCTS
ES2172248T3 (en) A PROCEDURE TO PREPARE A KAPPA-CASEINO GLICOPEPTIDE OR A DERIVATIVE OF THE SAME.
AU9352401A (en) Production process and composition of an enzymatic preparation, and its use for the treatment of domestic and industrial effluents of high fat, protein and/or carbohydrate content
DE69838615D1 (en) ppGpp-Synthetase and expression systems for the improved production of proteins
WO1999055885A3 (en) Novel serine protease capable of selective cleavage of insulin-like growth factor binding protein
WO2002024864A3 (en) Antisense modulation of syntaxin 4 interacting protein expression
WO2003060067A3 (en) P85-alpha nucleic acids, polypeptides and related methods
DE50207168D1 (en) Combination preparation for the treatment of immunological diseases
WO2002081665A3 (en) Implantation serine proteinases
WO2001057186A3 (en) Methods and compositions for diagnosis and treatment of cancer based on esf
ES2161146B1 (en) Set of antimicrobial compounds for vegetation consists of protein action products for incorporation of molecular oxygen in fatty acids